{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:42:37Z","timestamp":1759585357770,"version":"build-2065373602"},"reference-count":4,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.eururo.2022.01.014","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T07:18:41Z","timestamp":1643613521000},"page":"545-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Re: Belzutifan for Renal Cell Carcinoma in von Hippel\u2013Lindau Disease"],"prefix":"10.1016","volume":"81","author":[{"given":"Karim","family":"Bensalah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zine-Eddine","family":"Khene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Massard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2022.01.014_b0005","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2022.01.014_b0010","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00345-020-03441-3","article-title":"Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease","volume":"39","author":"Chahoud","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2022.01.014_b0015","article-title":"Natural history of Von Hippel-Lindau disease-associated and sporadic clear cell renal cell carcinoma: a comparative study","author":"Wang","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.eururo.2022.01.014_b0020","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1245\/s10434-016-5411-0","article-title":"Comparison of 1800 robotic and open partial nephrectomies for renal tumors","volume":"23","author":"Peyronnet","year":"2016","journal-title":"Ann Surg Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382200015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382200015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:11:06Z","timestamp":1759583466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228382200015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S030228382200015X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2022.01.014","relation":{},"ISSN":["0302-2838"],"issn-type":[{"type":"print","value":"0302-2838"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re: Belzutifan for Renal Cell Carcinoma in von Hippel\u2013Lindau Disease","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2022.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}